Article

Costs for glaucoma interventions

Author(s):

Doug Katsev, MD

How affordable are glaucoma interventions in developed and developing countries? Doug Katsev, MD, takes a look.

 

How affordable are glaucoma interventions in developed and developing countries? Doug Katsev, MD, takes a look.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
Related Content
Perceive Pharma closes funding for $15M Series A therapy
February 26th 2025

Perceive Pharma closes funding for $15M Series A therapy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Seonix Bio launches SightScore testing service for primary open-angle glaucoma
February 20th 2025

Seonix Bio launches SightScore testing service for primary open-angle glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Envision Summit 2025: Importance of comanagement in glaucoma treatment
February 15th 2025

Envision Summit 2025: Importance of comanagement in glaucoma treatment

MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma
February 15th 2025

MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma

© 2025 MJH Life Sciences

All rights reserved.